U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961565) titled 'PAS-004 in Adults With With Plexiform Neurofibromas (NF1)' on April 11.
Brief Summary: The main purpose of this clinical trial is to test PAS-004 in people with at least one symptomatic plexiform neurofibroma due to Neurofibromatosis Type 1 (NF1). The main questions it aims to answer are:
* How well participants are able tolerate different doses of PAS-004, and
* What side effects PAS-004 might have.
This study will have two parts, Part A and Part B. The main goal of Part A of this study is to learn more about how participants tolerate different doses of PAS-004, and what side effects PAS-004 might have. What we learn from Part A o...